WUXIF (Wuxi AppTec Co) Margin of Safety % (DCF Dividends Based) : 56.57% (As of May. 04, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Wuxi AppTec Co Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2025-05-04), Wuxi AppTec Co's Predictability Rank is 5-Stars. Wuxi AppTec Co's intrinsic value calculated from the Discounted Dividend model is $18.78 and current share price is $7.34. Consequently,

Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is 56.57%.

Competitive Comparison of Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based)

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based) falls into.

Save Embed

;

Save Embed

;

Wuxi AppTec Co Margin of Safety % (DCF Dividends Based) Calculation

Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)	=	(Intrinsic Value: DCF (Dividends Based)	-	Current Price)	/	Intrinsic Value: DCF (Dividends Based)
	=	(16.90	-	7.34)	/	16.90
	=	56.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Wuxi AppTec Co Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (OTCPK:WUXIF) » Definitions » Margin of Safety % (DCF Dividends Based)

Comparable Companies

Traded in Other Exchanges

WUXAY:USA 02359:Hong Kong WX8:Germany 603259:China

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.